Literature DB >> 19863245

Rapamycin: could it enhance vaccine efficacy?

Jae-Hwan Nam1.   

Abstract

EVALUATION OF: Araki K, Turner AP, Shaffer VO et al. mTOR regulates memory CD8 T-cell differentiation. Nature 460(7251), 108-112 (2009). The prime goal of vaccination is to induce an effective memory T-cell response, because memory T cells have a pivotal role in adaptive immunity. When a specific pathogen is encountered after vaccination, memory immune cells induce an adaptive immune response against that pathogen, which is faster and stronger than a primary immune response. Therefore, the development of a successful vaccine requires a T-cell response of adequate magnitude. Although many vaccines effectively induce protective immune responses against specific pathogens, some vaccines require boosting due to inadequate generation of memory immune cells. It was reported recently that rapamycin, which is used as an immunosuppressive drug for organ transplantation, stimulates the production of memory CD8 T cells. This means that rapamycin or related drugs could be used to enhance the efficacy of many types of vaccines.

Entities:  

Year:  2009        PMID: 19863245     DOI: 10.1586/erv.09.115

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  7 in total

1.  Sensitivity to Restimulation-Induced Cell Death Is Linked to Glycolytic Metabolism in Human T Cells.

Authors:  Sasha E Larsen; Abegail Bilenkin; Tatiana N Tarasenko; Swadhinya Arjunaraja; Jeffrey R Stinson; Peter J McGuire; Andrew L Snow
Journal:  J Immunol       Date:  2016-11-16       Impact factor: 5.422

2.  Rapamycin Treatment Reduces Acute Myocarditis Induced by Trypanosoma cruzi Infection.

Authors:  Thabata L A Duque; Cynthia M Cascabulho; Gabriel M Oliveira; Andrea Henriques-Pons; Rubem F S Menna-Barreto
Journal:  J Innate Immun       Date:  2019-12-04       Impact factor: 7.349

Review 3.  Immunotherapy for the treatment of breast cancer.

Authors:  Brenda Ernst; Karen S Anderson
Journal:  Curr Oncol Rep       Date:  2015-02       Impact factor: 5.075

4.  The correlation between the subsets of tumor infiltrating memory T cells and the expression of indoleamine 2,3-dioxygenase in gastric cancer.

Authors:  Rupeng Zhang; Hui Liu; Fangxuan Li; Hui Li; Jinpu Yu; Xiubao Ren
Journal:  Dig Dis Sci       Date:  2013-08-25       Impact factor: 3.199

Review 5.  Targeting T cell immunometabolism for cancer immunotherapy; understanding the impact of the tumor microenvironment.

Authors:  Mary B Mockler; Melissa J Conroy; Joanne Lysaght
Journal:  Front Oncol       Date:  2014-05-16       Impact factor: 6.244

6.  A human type 5 adenovirus-based Trypanosoma cruzi therapeutic vaccine re-programs immune response and reverses chronic cardiomyopathy.

Authors:  Isabela Resende Pereira; Glaucia Vilar-Pereira; Virgínia Marques; Andrea Alice da Silva; Bráulia Caetano; Otacilio Cruz Moreira; Alexandre Vieira Machado; Oscar Bruna-Romero; Maurício Martins Rodrigues; Ricardo Tostes Gazzinelli; Joseli Lannes-Vieira
Journal:  PLoS Pathog       Date:  2015-01-24       Impact factor: 6.823

7.  Rapamycin Improves the Response of Effector and Memory CD8+ T Cells Induced by Immunization With ASP2 of Trypanosoma cruzi.

Authors:  Barbara Ferri Moraschi; Isaú Henrique Noronha; Camila Pontes Ferreira; Leonardo M Cariste; Caroline B Monteiro; Priscila Denapoli; Talita Vrechi; Gustavo J S Pereira; Ricardo T Gazzinelli; Joseli Lannes-Vieira; Maurício M Rodrigues; Karina R Bortoluci; José Ronnie C Vasconcelos
Journal:  Front Cell Infect Microbiol       Date:  2021-05-25       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.